HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

High Ridge Brands Follows Expansion Overtures With Dr. Fresh Buy

This article was originally published in The Rose Sheet

Executive Summary

Dr. Fresh changes private equity owner hands with the announced acquisition, which adds REACH and Firefly toothbrushes and other oral-care products to High Ridge’s growing personal-care portfolio.

You may also be interested in...



Perrigo Oral Care Targets North American Value Tier With High Ridge Brands Buy

REACH and Dr. Fresh, as well as Firefly kids’ toothbrushes and mouth rinses featuring popular comic book and cartoon characters, will join Perrigo’s Ranir division under the $113m cash deal, which is subject to federal bankruptcy court approval but expected to close in the 2020 first quarter.

Portfolio Firm Glansaol Looks To Make Mark In Prestige, Led By Ex-Revlon CEO

More deals may be on the horizon for portfolio company Glansaol following its announced market entry with the acquisition of three prestige brands.

Cosmetic News In Brief: High Ridge Brands Eyeing Acquisitions; Arbonne Eyeliner Recall; More

High Ridge Brands is on the lookout for acquisition opportunities to grow its branded personal-care portfolio, which includes Zest cleansers in North American markets and a number of hair-care brands, while Curology aims to expand its platform for direct-to-consumer prescription skin care with $15m in new funding. More news in brief.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108993

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel